Who’s Going to PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

166 organizations and 203 speakers at PepTalk 2027, a ~1,000-person, mostly biopharma meeting of protein expression, purification and analytics scientists. As of Oct 17, 2026.

Showing 1–5 of 166 organizations

Organization	PepTalk 2027 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company developing antibodies, multispecifics and antibody-drug conjugates across oncology, respiratory, immunology and rare diseases.	Chair Mon Jan 18 8:50am–9:00am Chairperson's Remarks SYMPOSIUM: Predictive Protein Production Talk Mon Jan 18 9:30am–10:00am In silico Developability Assessment of Single- and Dual-Chain Antibodies SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Predictive Assembly and Purification Schema for Multispecific Biologics Using Integrated AI/ML and Experimental QC Workflows SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 11:20am–11:50am Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing Multispecifics Engineering & Design Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, Xencor, Eli Lilly +2 more Chair Tue Jan 19 1:25pm–1:30pm Chairperson's Remarks Recombinant Protein Production - Part 1 Talk Wed Jan 20 11:10am–11:40am Lipidic Platforms for Delivery of Complex Membrane Proteins in Lead Generation Recombinant Protein Production - Part 1 Talk Wed Jan 20 2:30pm–3:00pm End-to-End Automation of Intact Mass Spectrometry QC for Integrated Purification and Quality Workflows in High-Throughput Biologics Production Tools for Purification and Quality Talk Thu Jan 21 9:10am–9:40am Fit-for-Purpose Antibody Purification: A Strategic Guide to Scale, Selection, and Automation Readiness Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Improving Dual Targeting Selectivity in T Cell Engagers via Synapse-Gated and Affinity-Tuned Trispecific Antibody Design Emerging T Cell Engagers Talk Thu Jan 21 1:40pm–2:00pm Scaling the Start: High-Throughput Generation of Transfection-Ready DNA and Scalable Workflows for Rapid Antibody Production Recombinant Protein Production - Part 2 / Tools for Purification and Quality Talk Thu Jan 21 2:40pm–3:10pm Rational Antibody Engineering for Multiparameter Developability Enhancement Biophysical Methods and Models Panel Thu Jan 21 3:00pm–3:40pm Building Effective Cross-Functional Protein Production Teams Recombinant Protein Production - Part 2 / Tools for Purification and Quality · with Thomson Instrument Company, UCLA, BioMarin +1 more
Genentech South San Francisco, CA
gene.com Large pharma Roche Group biotechnology company discovering and developing antibody, peptide and other protein medicines.	Talk Mon Jan 18 10:00am–10:30am A Machine-Learning–Enabled Venom Peptide Platform for Rapid Drug Discovery SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Development of LRRC15-Binding Disulfide-Constrained Peptides for PET Imaging of Cancer-Associated Fibroblasts SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Talk Mon Jan 18 4:00pm–4:30pm Mirror-Image mRNA Display Uncovers Isoform-Selective D-Peptide Macrocycles Targeting a Cryptic KRAS Pocket SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Panel Mon Jan 18 4:30pm–5:00pm Breaking Down Silos—Integrating Disciplines to Accelerate Peptide Drug Discovery SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact · with EPOC Scientific, University of Florida, University of Queensland +1 more Talk Tue Jan 19 11:20am–11:50am De novo Design of Miniprotein Cytokine Mimics Targeting IL4Ra by Combining Diffusion Models, MD Simulations, and Phage Display Automation in Protein Discovery / Peptide Discovery & Engineering Predictive and AI-driven protein science Talk Tue Jan 19 2:30pm–3:00pm Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Automation in Protein Discovery Panel Tue Jan 19 5:45pm–6:05pm Women in AI Meet-Up Plenary · with Novo Nordisk Chair Wed Jan 20 8:15am–8:20am Chairperson's Remarks Peptide Discovery & Engineering Talk Wed Jan 20 9:35am–10:05am What Does the Future Hold for Antibody "Lab-in-the-Loop" Methods? Analytical Intelligence Talk Wed Jan 20 9:40am–10:05am Discovery and Characterization of Potent Macrocycle Inhibitors Peptide Discovery & Engineering Talk Wed Jan 20 3:00pm–3:30pm Overcoming in-Process Autolysis: A Robust Purification Strategy for Difficult-to-Purify Recombinant Peptidases Tools for Purification and Quality
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, called MSD outside the US and Canada, with biologics, vaccines and macrocyclic peptide research.	Talk Mon Jan 18 10:00am–10:30am When Execution is No Longer the Bottleneck: Reimagining Design of Experiments for Predictive, Data-Driven Protein Production SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 9:10am–9:40am Implementing Agentic AI and Autonomous Systems in Analytical Development Analytical Intelligence Talk Tue Jan 19 9:40am–10:10am Discovery of an NRAS Isoform and Activation-State-Selective Macrocyclic Peptide Automation in Protein Discovery / Peptide Discovery & Engineering Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Analytical Intelligence Talk Wed Jan 20 11:10am–11:40am Modeling Stability to Support Biotherapeutics Development Analytical Intelligence Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Tools for Purification and Quality Talk Wed Jan 20 3:00pm–3:30pm Investigation of Low Molecular Weight (LMW) Formation of a Multispecific Antibody by Protease Inhibitor Study Biophysical Methods and Models Talk Wed Jan 20 3:30pm–4:00pm Rapid Benchtop ¹H-NMR for Real-Time Monitoring of Purification Performance and Product Quality Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Scaling Formulation Development with 384-Well ELISA for Stability, Potency, and Process Monitoring Tools for Purification and Quality Talk Thu Jan 21 2:55pm–3:20pm Enabling Oral and Parenteral GLP-1 Delivery through Biophysical and Molecular Characterizations Peptide Therapeutics: Emerging Modalities & Development
Sanofi Paris, France
sanofi.com Large pharma French pharmaceutical company with marketed medicines and vaccines, and biologics research that includes nanobody, multispecific and AI-based protein design.	Talk Mon Jan 18 1:35pm–2:05pm Two Cell Lines, One Goal: Enabling Reliable Cell-Based Assay Critical Reagent Production SYMPOSIUM: (Re) Discovering Protein Expression Platforms Talk Tue Jan 19 1:30pm–2:00pm AI-Driven Design of Mono- and Multispecific VHH Therapeutics Multispecifics Engineering & Design Talk Wed Jan 20 8:35am–9:05am Membrane Protein Expression and Production in Pharma R&D Pipelines Recombinant Protein Production - Part 1 Talk Wed Jan 20 3:30pm–4:00pm Strategic Non-Optimal Codon Usage Reduces Bispecific Protein Mispairing Recombinant Protein Production - Part 2 Chair Thu Jan 21 1:35pm–1:40pm Chairperson's Remarks Biophysical Methods and Models Talk Thu Jan 21 1:40pm–2:10pm High-Throughput Cryo Electron Microscopy and Machine Learning for Biologics Engineering: From Pipeline to Decisions Biophysical Methods and Models
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Jan 19 11:50am–12:20pm From Data Silos to Shared Insights: Democratizing Data and AI for Accelerated Biotherapeutics Analytics and Decision Making Analytical Intelligence Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Novo Nordisk, Prescient Design, Generate Biomedicines Predictive and AI-driven protein science Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Wed Jan 20 5:40pm–6:10pm Predictive Accelerated Stability Studies: A Strategic Approach to Developing Oligonucleotide Therapeutics Biophysical Methods and Models

Instantly find 20 buyers from companies at PepTalk 2027

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where is PepTalk 2027?

PepTalk 2027 runs January 18–21, 2027, at the Omni La Costa Resort & Spa in Carlsbad, CA.

Where is the PepTalk 2027 program?

This guide lists every organization on the PepTalk 2027 program with its sessions; the full program is on the official website.

How do I register for PepTalk 2027?

Fees and registration are on the organizer's registration page.

What conference is this?

PepTalk is a protein science and production week, held January 18–21, 2027 at the Omni La Costa Resort & Spa in Carlsbad, California. It brings together protein expression, purification, analytics and engineering scientists from biopharma and academia with the instrument, reagent, CRO and software companies that serve them, across tracks and symposia on recombinant protein production, expression platforms, purification and quality, analytical and biophysical methods, automation, display of biologics, multispecifics and T cell engagers, and peptide drug discovery and development.

What is in this guide?

Every organization we can place at PepTalk 2027: 203 speakers from the public agenda (225 talks, panels, roundtables and sponsored presentations) rolled up to their companies and institutions, the 50 exhibitors from the floor plan with their booth numbers, and 18 sponsors with their level — 166 organizations in one list. Speakers appear as job titles, never by name. The organizers publish an attendee list nearer the meeting.

How are organizations typed?

By the role an organization plays in protein science: drug developers (large pharma and biotech), then the companies around them — CROs and CDMOs, discovery platforms, reagent and instrument makers, software and AI companies, and consultancies and other services — and academic, government and non-profit bodies. The topic filters come from the track a talk sits in (both tracks for a joint session); a plenary session's topics are judged from its title.

How current is it?

Pulled from the public track agendas, floor plan and sponsor list on October 17, 2026, about three months before the meeting. The organizers add talks, exhibitors and sponsors until the meeting, so the lists will grow.

Organizations with their own page

101 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction